Think you've nailed in Ryan. A positive update by the market will wait for it to be backed up by revenue in the 4C (and margin calculations in the same).Still, it's better than naught.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025